Elanco Animal Health Incorporated (ETR:5EA)

Elanco Animal Health Statistics

Total Valuation

ETR:5EA has a market cap or net worth of EUR 10.83 billion. The enterprise value is 14.21 billion.

Market Cap	10.83B
Enterprise Value	14.21B

Important Dates

The last earnings date was Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	497.17M
Shares Outstanding	n/a
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	108.88%
Float	492.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.90
PS Ratio	2.70
PB Ratio	1.94
P/TBV Ratio	n/a
P/FCF Ratio	44.77
P/OCF Ratio	22.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.71, with an EV/FCF ratio of 58.75.

EV / Earnings	-71.92
EV / Sales	3.48
EV / EBITDA	16.71
EV / EBIT	63.28
EV / FCF	58.75

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.68.

Current Ratio	2.17
Quick Ratio	1.00
Debt / Equity	0.68
Debt / EBITDA	4.53
Debt / FCF	15.65
Interest Coverage	1.06

Financial Efficiency

Return on equity (ROE) is -3.67% and return on invested capital (ROIC) is 2.47%.

Return on Equity (ROE)	-3.67%
Return on Assets (ROA)	1.25%
Return on Invested Capital (ROIC)	2.47%
Return on Capital Employed (ROCE)	2.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	416,142
Profits Per Employee	-20,476
Employee Count	9,650
Asset Turnover	0.36
Inventory Turnover	1.28

Taxes

In the past 12 months, ETR:5EA has paid 6.81 million in taxes.

Income Tax	6.81M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	20.70
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.52
Average Volume (20 Days)	35

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.13

Income Statement

In the last 12 months, ETR:5EA had revenue of EUR 4.02 billion and -197.59 million in losses. Loss per share was -0.40.

Revenue	4.02B
Gross Profit	2.21B
Operating Income	220.59M
Pretax Income	-190.78M
Net Income	-197.59M
EBITDA	773.34M
EBIT	220.59M
Loss Per Share	-0.40

Balance Sheet

The company has 464.18 million in cash and 3.79 billion in debt, with a net cash position of -3.32 billion.

Cash & Cash Equivalents	464.18M
Total Debt	3.79B
Net Cash	-3.32B
Net Cash Per Share	n/a
Equity (Book Value)	5.58B
Book Value Per Share	11.22
Working Capital	1.59B

Cash Flow

In the last 12 months, operating cash flow was 476.95 million and capital expenditures -235.07 million, giving a free cash flow of 241.88 million.

Operating Cash Flow	476.95M
Capital Expenditures	-235.07M
Depreciation & Amortization	560.24M
Net Borrowing	-235.66M
Free Cash Flow	241.88M
FCF Per Share	n/a

Margins

Gross margin is 54.99%, with operating and profit margins of 5.49% and -4.92%.

Gross Margin	54.99%
Operating Margin	5.49%
Pretax Margin	-4.75%
Profit Margin	-4.92%
EBITDA Margin	19.26%
EBIT Margin	5.49%
FCF Margin	6.02%

Dividends & Yields

ETR:5EA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.18%
Shareholder Yield	0.18%
Earnings Yield	-1.82%
FCF Yield	2.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:5EA has an Altman Z-Score of 1.03 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	6